Centre de Documentation Campus Montignies
Horaires :
Lundi : 8h-18h30
Mardi : 8h-17h30
Mercredi 9h-16h30
Jeudi : 8h30-18h30
Vendredi : 8h30-12h30 et 13h-14h30
Votre centre de documentation sera exceptionnellement fermé de 12h30 à 13h ce lundi 18 novembre.
Egalement, il sera fermé de 12h30 à 13h30 ce mercredi 20 novembre.
Lundi : 8h-18h30
Mardi : 8h-17h30
Mercredi 9h-16h30
Jeudi : 8h30-18h30
Vendredi : 8h30-12h30 et 13h-14h30
Votre centre de documentation sera exceptionnellement fermé de 12h30 à 13h ce lundi 18 novembre.
Egalement, il sera fermé de 12h30 à 13h30 ce mercredi 20 novembre.
Bienvenue sur le catalogue du centre de documentation du campus de Montignies.
Détail de l'auteur
Auteur Deborah A. Hebert |
Documents disponibles écrits par cet auteur
Ajouter le résultat dans votre panier Faire une suggestion Affiner la recherche
Examining a new functional electrical stimulation therapy with people with severe upper extremity hemiparesis and chronic stroke: A feasibility study / Deborah A. Hebert in The British Journal of Occupational Therapy, Vol.80 Issue 11 (Novembre 2017)
[article]
Titre : Examining a new functional electrical stimulation therapy with people with severe upper extremity hemiparesis and chronic stroke: A feasibility study Type de document : texte imprimé Auteurs : Deborah A. Hebert ; James M. Bowen ; Cindy Ho ; [et al...] Année de publication : 2017 Article en page(s) : p. 651-659 Langues : Anglais (eng) Mots-clés : accident vasculaire cérébral hémiparésie rééducation membre supérieur stimulation électrique Résumé : Introduction
Upper extremity impairment post-stroke is common and results in decreased occupational engagement. For those with chronic stroke and severe hemiparesis, few treatment options are available. MyndMove™ is a functional electrical stimulation technology programmed to stimulate up to eight muscle groups in reach and grip patterns. A pre–post, cohort, feasibility study was conducted to inform the design of a randomized controlled trial examining the effectiveness of MyndMove™ therapy.
Method
Individuals enrolled had chronic severe upper extremity hemiparesis following a stroke (> 6 months) with Chedoke-McMaster Stroke Assessment Stage 1–2 (arm and hand) and a Fugl-Meyer Upper Extremity score less than 19. Treatment with Myndmove™, consisting of 20 one-hour sessions, 3–5 times per week over 4–6 weeks was provided.
Results
Of 25 enrolled participants, 24 (96%) completed treatment. Fifty-eight percent (14/24) of the participants demonstrated improvement equal to or exceeding the minimal clinically important difference of five on the Fugl-Meyer Upper Extremity test. Mean change from baseline Fugl-Meyer Upper Extremity overall score was 7.1 (SD 5.0) (p < 0.001). Mean time to complete treatment was 40 days (SD 6.0).
Conclusion
MyndMove™ therapy is feasible to deliver within outpatient settings and may be a suitable function-based treatment option for severe chronic stroke upper extremity impairment.Permalink : ./index.php?lvl=notice_display&id=57794
in The British Journal of Occupational Therapy > Vol.80 Issue 11 (Novembre 2017) . - p. 651-659[article] Examining a new functional electrical stimulation therapy with people with severe upper extremity hemiparesis and chronic stroke: A feasibility study [texte imprimé] / Deborah A. Hebert ; James M. Bowen ; Cindy Ho ; [et al...] . - 2017 . - p. 651-659.
Langues : Anglais (eng)
in The British Journal of Occupational Therapy > Vol.80 Issue 11 (Novembre 2017) . - p. 651-659
Mots-clés : accident vasculaire cérébral hémiparésie rééducation membre supérieur stimulation électrique Résumé : Introduction
Upper extremity impairment post-stroke is common and results in decreased occupational engagement. For those with chronic stroke and severe hemiparesis, few treatment options are available. MyndMove™ is a functional electrical stimulation technology programmed to stimulate up to eight muscle groups in reach and grip patterns. A pre–post, cohort, feasibility study was conducted to inform the design of a randomized controlled trial examining the effectiveness of MyndMove™ therapy.
Method
Individuals enrolled had chronic severe upper extremity hemiparesis following a stroke (> 6 months) with Chedoke-McMaster Stroke Assessment Stage 1–2 (arm and hand) and a Fugl-Meyer Upper Extremity score less than 19. Treatment with Myndmove™, consisting of 20 one-hour sessions, 3–5 times per week over 4–6 weeks was provided.
Results
Of 25 enrolled participants, 24 (96%) completed treatment. Fifty-eight percent (14/24) of the participants demonstrated improvement equal to or exceeding the minimal clinically important difference of five on the Fugl-Meyer Upper Extremity test. Mean change from baseline Fugl-Meyer Upper Extremity overall score was 7.1 (SD 5.0) (p < 0.001). Mean time to complete treatment was 40 days (SD 6.0).
Conclusion
MyndMove™ therapy is feasible to deliver within outpatient settings and may be a suitable function-based treatment option for severe chronic stroke upper extremity impairment.Permalink : ./index.php?lvl=notice_display&id=57794 Exemplaires (1)
Cote Support Localisation Section Disponibilité Revue Revue Centre de Documentation HELHa Campus Montignies Armoires à volets Document exclu du prêt - à consulter sur place
Exclu du prêt